Each preparation yields neurons from pooled hippocampi of one E18 litter (8-12 embryos). Plate technical replicates of ≥3 coverslips per condition and biological replicates from ≥3 independent dissections (different litters) for any downstream comparison. Plating densities: 50,000 cells/cm² (low, for morphology/imaging) and 100,000 cells/cm² (high, for biochemistry). Viability assessed at plating (trypan blue) and culture health monitored at DIV1, 4, 7, 14. Half-medium changes every 3-4 days.
BSL-1; embryonic rodent tissue under IACUC approval. Hazards: papain/trypsin are sensitizers (gloves, avoid aerosols); AraC is a cytotoxic antimetabolite (chemotherapeutic) — handle with nitrile gloves in a BSC, collect AraC-contaminated waste as cytotoxic waste. Borate buffer is an irritant. Work in a Class II biosafety cabinet to maintain sterility and personal protection. Sharps (scalpels, glass pipettes) into sharps containers. Animal waste per institutional biohazard policy.
Purity control: stain a coverslip for MAP2 (neurons) and GFAP (astrocytes) at DIV14; expect >90% MAP2+. Viability control: trypan blue exclusion at plating should show >85% viable cells. Coating control: a non-PDL-coated coverslip should show poor adhesion/no neurite extension, confirming PDL necessity. Density control: parallel plates at low and high density confirm the effect of density on survival and network formation. Medium control: a no-B-27 arm demonstrates the survival dependence on B-27 supplement.
Healthy cultures show phase-bright somata with smooth, extending neurites by DIV1, an elaborated dendritic arbor by DIV7, and a dense synaptic network by DIV14. Viability at plating >85%; purity >90% MAP2+ at DIV14. Spontaneous calcium transients/network bursts appear by DIV10-14. Synapsin/PSD-95 puncta density of ~0.2-0.5 puncta/µm of dendrite at DIV14-21. Minimal glial carpet if AraC used; mild glial layer supports survival if AraC omitted.
To dissect hippocampi from embryonic day 18 (E18) rat embryos, dissociate them enzymatically and mechanically into a single-cell suspension, and plate neurons at defined density on poly-D-lysine-coated coverslips in serum-free Neurobasal/B-27 medium. The goal is a culture that reaches >90% neuronal purity (MAP2+), forms dense synaptic networks by DIV14, and remains viable through DIV21 for downstream functional and morphological assays.
Independent variables: plating density, coating substrate (PDL ± laminin), AraC treatment, embryonic age. Dependent variables: neuronal viability (% live), neuronal purity (% MAP2+), synapse density (synapsin/PSD-95 puncta at DIV14), and neurite outgrowth. Controlled variables: medium formulation (Neurobasal/B-27/GlutaMAX), CO2 (5%), temperature (37 °C), feeding schedule, coverslip lot, dissociation enzyme and time.
We hypothesize that E18 hippocampal neurons plated at 50,000-75,000 cells/cm² on poly-D-lysine in Neurobasal/B-27 will, without serum, mature into a synaptically connected network exhibiting spontaneous activity by DIV10-14, and that glial proliferation will be suppressed sufficiently (with optional AraC) to maintain a neuron-dominated culture without compromising neuronal survival.
Cell counts and viability computed from hemocytometer (live/total). Purity quantified by counting MAP2+ vs DAPI+ nuclei across ≥5 fields per coverslip in Fiji/ImageJ. Synapse density measured by thresholded puncta counts (synapsin/PSD-95) normalized to MAP2+ dendrite length using the Fiji Puncta Analyzer or SynQuant. Neurite length measured with the Simple Neurite Tracer (SNT) plugin. Report per-coverslip and per-dissection means.
Compare conditions (e.g., density, AraC) by one-way ANOVA with Tukey post-hoc (alpha = 0.05), treating independent dissections as the biological unit (n ≥ 3 dissections). For purity/viability proportions use a generalized linear model or arcsine-transformed ANOVA. Power: detecting a 15% difference in survival at 80% power (SD ~10%) requires n ≈ 4 dissections. Report n at both coverslip and dissection levels and avoid pseudoreplication.